These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fibrosis due to ergot derivatives: exposure to risk should be weighed up. Prescrire Int; 2002 Dec; 11(62):186-9. PubMed ID: 12472101 [TBL] [Abstract][Full Text] [Related]
4. [Retroperitoneal fibrosis due to ergotamine. Apropos a case]. Moltó Ripoll F; Merenciano Cortina FJ; Herraiz Romero I; Vilas Ferrol I; Fernández-Moscoso López-Duran A; Muñoz Nuñez C; Martínez Salinas P Arch Esp Urol; 1995 May; 48(4):400-3. PubMed ID: 7598553 [TBL] [Abstract][Full Text] [Related]
5. Retroperitoneal fibrosis associated with methysergide therapy for migraine. Seymour R Med J Aust; 1968 Jan; 1(2):59-60. PubMed ID: 5639831 [No Abstract] [Full Text] [Related]
6. [Methysergide-induced fibrosis. Directives for preventive treatment of migraine with methysergide]. Mondrup K; Nielsen HK Ugeskr Laeger; 1979 Jan; 141(5):284-7. PubMed ID: 760308 [No Abstract] [Full Text] [Related]
7. Effects on arterial receptors of ergot derivatives used in migraine. Müller-Schweinitzer E; Fanchamps A Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676 [No Abstract] [Full Text] [Related]
8. Retroperitoneal fibrosis after methysergide. Sandel JM; Hayton AC; Law PW N Z Med J; 1967 May; 66(417):310. PubMed ID: 5230123 [No Abstract] [Full Text] [Related]
9. [A case of retroperitoneal fibrosis following dihydroergotamine therapy, with special reference to partial diabetes insipidus and positive Ga scan]. Oguma Y; Nishimura M; Abe S; Hasegawa H; Kawakami Y; Ide H Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):864-70. PubMed ID: 6593386 [No Abstract] [Full Text] [Related]
10. [Retroperitoneal fibrosis secondary to ergotamine use]. Martín Azcárate MD; Hernández Muro G; Isusquiza I An Med Interna; 2006 Apr; 23(4):193-4. PubMed ID: 16796416 [No Abstract] [Full Text] [Related]
11. Metabolism of methysergide and retroperitoneal fibrosis. Bianchine JR; Friedman AP Arch Intern Med; 1970 Aug; 126(2):252-4. PubMed ID: 5433064 [No Abstract] [Full Text] [Related]
12. Ergotamine as a possible cause of retroperitoneal fibrosis. Lepage-Savary D; Vallières A Clin Pharm; 1982; 1(2):179-80. PubMed ID: 7185517 [No Abstract] [Full Text] [Related]
13. Dihydroergotamine: role in the treatment of migraine. Schürks M Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283 [TBL] [Abstract][Full Text] [Related]
14. Pleurisy and fibrosis of the pleura during methysergide treatment of hemicrania. Kok-Jensen A; Lindeneg O Scand J Respir Dis; 1970; 51(3):218-22. PubMed ID: 5508408 [No Abstract] [Full Text] [Related]
15. Retroperitoneal fibrosis, methysergide and malignant lymphoma. Hurley BP; Macarthur EB; Utley GL Aust N Z J Med; 1978 Aug; 8(4):417-9. PubMed ID: 282856 [TBL] [Abstract][Full Text] [Related]
16. Treatment of migraine headache. Bianchine JR; Speed WG Johns Hopkins Med J; 1968 Jul; 123(1):38-40. PubMed ID: 5667657 [No Abstract] [Full Text] [Related]
17. Letter: Oral dihydroergotamine in management of cluster headache. Herzberg L; Lenman JA Br Med J; 1976 Jan; 1(6001):96. PubMed ID: 1244959 [No Abstract] [Full Text] [Related]
18. [Retroperitoneal fibrosis (Ormond's disease)]. Dölle W Ergeb Inn Med Kinderheilkd; 1972; 32():1-30. PubMed ID: 4556561 [No Abstract] [Full Text] [Related]